UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase I Study of Pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors

Clinical cancer research, 2015-10, Vol.21 (19), p.4286-4293

2015

Volltextzugriff (PDF)

Abstract P1-18-10: A clinical study of samuraciclib (CT7001), a first-in-class, oral, selective inhibitor of CDK7, in patients with advanced triple negative breast cancer (TNBC)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P1-P1-18-10

2022

Volltextzugriff (PDF)

Abstract GS3-10: Study of samuraciclib (CT7001), a first-in-class, oral, selective inhibitor of CDK7, in combination with fulvestrant in patients with advanced hormone receptor positive HER2 negative breast cancer (HR+BC)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.GS3-10-GS3-10

2022

Volltextzugriff (PDF)

Phase II Trial of Docetaxel in Asian Patients with Inoperable Stage III Non-Small Cell Lung Cancer

Acta oncologica, 2000, Vol.39 (2), p.225-229

2000

Volltextzugriff (PDF)

Enzastaurin – From bench to bedside, and back

European journal of cancer supplements, 2006-06, Vol.4 (6), p.4-4

Lehnert, Manfred

2006

Volltextzugriff (PDF)

Chemotherapy resistance in breast cancer

Anticancer research, 1998-05, Vol.18 (3C), p.2225

Lehnert, M

1998

Volltextzugriff (PDF)

A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer

Oncotarget, 2015-06, Vol.6 (16), p.14139-14152

2015

Volltextzugriff (PDF)

Intermittent exposure to doxorubicin in vitro selects for multifactorial non‐P‐glycoprotein‐associated multidrug resistance in RPMI 8226 human myeloma cells

British journal of haematology, 1997-04, Vol.97 (1), p.65-75

1997

Volltextzugriff (PDF)

Methods to detect P-glycoprotein-associated multidrug resistance in patients tumors : Consensus recommendations

Cancer research (Chicago, Ill.), 1996-07, Vol.56 (13), p.3010-3020

1996

Volltextzugriff (PDF)

Gemcitabine and split-dose paclitaxel or docetaxel in metastatic breast cancer: A randomised phase II study

European journal of cancer (1990), 2006-08, Vol.42 (12), p.1797-1806

2006

Volltextzugriff (PDF)

Reversal of P-glycoprotein-associated multidrug resistance: The challenge continues

European journal of cancer (1990), 1993, Vol.29 (4), p.636-638

Lehnert, Manfred

1993

Volltextzugriff (PDF)

Randomized Comparison of Total Androgen Blockade Alone versus Combined with Weekly Epirubicin in Advanced Prostate Cancer

European urology, 1997-01, Vol.32 (Suppl 3), p.81-85

1997

Volltextzugriff (PDF)

Phase II Trial of Gemcitabine-Carboplatin-Paclitaxel as Neoadjuvant Chemotherapy for Operable Non-small Cell Lung Cancer

Journal of thoracic oncology, 2006-02, Vol.1 (2), p.135-140

2006

Volltextzugriff (PDF)

Reversal of multidrug resistance in breast cancer: Many more open questions than answers

Annals of oncology, 1993-01, Vol.4 (1), p.11-13

Lehnert, M

1993

Volltextzugriff (PDF)

Foreword

European journal of cancer (1990), 1996-06, Vol.32 (6), p.911

1996

Volltextzugriff (PDF)

Multidrug-Resistant Myeloma: Laboratory and Clinical Effects of Verapamil as a Chemosensitizer

Blood, 1991-07, Vol.78 (1), p.44-50

1991

Volltextzugriff (PDF)

Multidrug resistance in cancer

European journal of cancer (1990), 1996, Vol.32 (6)

1996

Volltextzugriff (PDF)

Phase II Trial of Gemcitabine-Carboplatin-Paclitaxel as Neoadjuvant Chemotherapy for Operable Non-small Cell Lung Cancer

Journal of thoracic oncology, 2006-02, Vol.1 (2), p.135-140

2006

Volltextzugriff (PDF)

Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: a Cancer Therapeutics Research Group study

Cancer chemotherapy and pharmacology, 2003-08, Vol.52 (2), p.153-158

2003

Volltextzugriff (PDF)

P-201 First-line chemotherapy with gemzar ® (gemcitabine, GEM) and cisplatin (CIs) in Asian patients with advanced non-small cell lung cancer (NSCLC) — A prospective observational study

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S142-S142

2003

Volltextzugriff (PDF)

Synergistic Inhibition by Verapamil and Quinine of P-Glycoprotein-Mediated Multidrug Resistance in a Human Myeloma Cell Line Model

Blood, 1991-01, Vol.77 (2), p.348-354

1991

Volltextzugriff (PDF)

Dexverapamil: A clinical approach to circumvention of multidrug resistance

Journal of cancer research and clinical oncology, 1995-03, Vol.121 (S3), p.R1-R1

1995

Volltextzugriff (PDF)

Sensitive and rapid bioassay for analysis of P-glycoprotein-inhibiting activity of chemosensitizers in patient serum

Clinical cancer research, 1996-02, Vol.2 (2), p.403-410

1996

Volltextzugriff (PDF)

Tumor necrosis factor α is a powerful apoptotic inducer in lymphoid leukemic cells expressing the P‐170 glycoprotein

International journal of cancer, 1996-07, Vol.67 (2), p.238-247

1996

Volltextzugriff (PDF)

Die Schlangen Deutschlands Verbreitung, Merkmale und Giftigkeit

Pharmazie in unserer Zeit, 1994, Vol.23 (2), p.81-92

1994

Volltextzugriff (PDF)

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(101)

Publikationsform

Sprache

Englisch
(88)
Deutsch
(23)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Life Sciences & Biomedicine
(56)
Humans
(53)
Male
(38)
Adult
(35)
Female
(27)
Biological And Medical Sciences
(25)
Endocrinology & Metabolism
(21)
Medical Sciences
(20)
Middle Aged
(17)
Christianity
(14)
Young Adult
(14)
Aged
(13)
Insulin
(12)
Oncology
(12)
Fundamental And Applied Biological Sciences. Psychology
(10)
Blood Glucose - Metabolism
(9)
Body Mass Index
(9)
Endocrinopathies
(9)
Glucose
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phase I Study of Pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors

Abstract P1-18-10: A clinical study of samuraciclib (CT7001), a first-in-class, oral, selective inhibitor of CDK7, in patients with advanced triple negative breast cancer (TNBC)

Abstract GS3-10: Study of samuraciclib (CT7001), a first-in-class, oral, selective inhibitor of CDK7, in combination with fulvestrant in patients with advanced hormone receptor positive HER2 negative breast cancer (HR+BC)

Phase II Trial of Docetaxel in Asian Patients with Inoperable Stage III Non-Small Cell Lung Cancer

Enzastaurin – From bench to bedside, and back

Chemotherapy resistance in breast cancer

A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer

Intermittent exposure to doxorubicin in vitro selects for multifactorial non‐P‐glycoprotein‐associated multidrug resistance in RPMI 8226 human myeloma cells

Methods to detect P-glycoprotein-associated multidrug resistance in patients tumors : Consensus recommendations

Gemcitabine and split-dose paclitaxel or docetaxel in metastatic breast cancer: A randomised phase II study

Reversal of P-glycoprotein-associated multidrug resistance: The challenge continues

Randomized Comparison of Total Androgen Blockade Alone versus Combined with Weekly Epirubicin in Advanced Prostate Cancer

Phase II Trial of Gemcitabine-Carboplatin-Paclitaxel as Neoadjuvant Chemotherapy for Operable Non-small Cell Lung Cancer

Reversal of multidrug resistance in breast cancer: Many more open questions than answers

Foreword

Multidrug-Resistant Myeloma: Laboratory and Clinical Effects of Verapamil as a Chemosensitizer

Multidrug resistance in cancer

Phase II Trial of Gemcitabine-Carboplatin-Paclitaxel as Neoadjuvant Chemotherapy for Operable Non-small Cell Lung Cancer

Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: a Cancer Therapeutics Research Group study

P-201 First-line chemotherapy with gemzar ® (gemcitabine, GEM) and cisplatin (CIs) in Asian patients with advanced non-small cell lung cancer (NSCLC) — A prospective observational study

Synergistic Inhibition by Verapamil and Quinine of P-Glycoprotein-Mediated Multidrug Resistance in a Human Myeloma Cell Line Model

Dexverapamil: A clinical approach to circumvention of multidrug resistance

Sensitive and rapid bioassay for analysis of P-glycoprotein-inhibiting activity of chemosensitizers in patient serum

Tumor necrosis factor α is a powerful apoptotic inducer in lymphoid leukemic cells expressing the P‐170 glycoprotein

Die Schlangen Deutschlands Verbreitung, Merkmale und Giftigkeit

Suchergebnisse filtern